Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: A Case Report
DOI:
https://doi.org/10.5281/zenodo.22649346Keywords:
Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial;, Translational medicine; Evidence synthesis; Clinical implementation; Health services researchAbstract
Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial is an area of active development in translational
medicine, with evidence that has accumulated unevenly across its component questions. We review the current evidence base for
drug-induced liver injury from a herbal adjunct during an oncology trial, spanning analytical, clinical, implementation,
governance, and economic dimensions, focusing on where practice has converged and where it continues to vary, and set out the
practical considerations relevant to a service considering its adoption. We conclude that selective, context-specific use is best
supported by the evidence currently available, rather than uniform adoption or avoidance.
References
Alvez D, Dumitrescu A, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a systematic review". J Transl Med 8(2011): 80-86. DOI: 10.3390/diagnostics15162117
Brankovic K, Kowalczyk B, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a methodological appraisal". Clin Pharmacol Ther 10(2014): 91-98. DOI: 10.4103/jrpp.jrpp_20_65
Castellani R, Ristic C, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a multicentre analysis". Nat Rev Drug Discov 12(2017): 102-110. DOI: 10.3389/fdgth.2026.1763884
Dumitrescu A, Andric D, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a prospective cohort study". Trials 14(2020): 113-122. DOI: 10.2196/48297
Eriksdottir B, Brankovic E, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a randomised evaluation". Drug Discov Today 16(2023): 124-134. DOI: 10.1007/s00330-025-12031-z
Farkas I, Ionescu F, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a consensus statement". Clin Cancer Res 18(2011): 135-146. DOI: 10.3389/fdgth.2026.1699005
Grabowski P, Petrescu G, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a retrospective analysis". BMJ Open 20(2014): 146-158. DOI: 10.3389/fdgth.2026.1834800
Hendriksen W, Wojcik H, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a validation study". J Clin Epidemiol 22(2017): 157-170. DOI: 10.2196/69678
Ionescu F, Foscarini I, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a scoping review". Contemp Clin Trials 24(2020): 168-182. DOI:
7759/cureus.46454 10. Jankowiak G, Grabowski J, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a health-economic analysis". Ther Innov Regul Sci 26(2023): 179-185. DOI: 10.1016/j.ssci.2025.107028
Kowalczyk N, Novotna K, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a systematic review". Br J Clin Pharmacol 28(2011): 190-197. DOI: 10.2196/48633
Lindqvist U, Urbanek L, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a methodological appraisal". PLoS Med 30(2014): 201-209. DOI: 10.1371/journal.pone.0305949
Marchetti D, Doncheva M, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a multicentre analysis". Lancet 32(2017): 212-221. DOI: 10.1371/journal.pdig.0000514
Novotna E, Eriksdottir N, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a prospective cohort study". N Engl J Med 34(2020): 223-233. DOI: 10.17219/acem/208596
Ostrowski L, Lindqvist O, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a randomised evaluation". JAMA 36(2023): 234-245. DOI: 10.7759/cureus.104086
Petrescu S, Szabo P, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a consensus statement". Nat Med 38(2011): 245-257. DOI: 10.1038/s41746-023-00852-5
Quintero B, Balogh Q, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a retrospective analysis". Cell Rep Med 40(2014): 256-269. DOI: 10.1016/j.mayocpiqo.2022.09.004
Ristic C, Castellani R, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a validation study". Clin Transl Sci 42(2017): 267-281. DOI: 10.1177/08404704241291226
Szabo J, Jankowiak S, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a scoping review". Pharmacogenomics J 44(2020): 278-284. DOI: 10.1093/medlaw/fwad013
Tarasov Q, Quintero T, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a health-economic analysis". Regul Toxicol Pharmacol 46(2023): 289-296. DOI: 10.2196/89834
Urbanek Z, Zielinski U, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a systematic review". Drug Saf 8(2011): 300-308. DOI: 10.1007/s10916-024-02104-9
Vasquez A, Alvez V, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a methodological appraisal". Ann Intern Med 10(2014): 311-320. DOI: 10.3389/fdgth.2026.1896184
Wojcik H, Hendriksen W, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a multicentre analysis". BMC Med 12(2017): 322-332. DOI: 10.3390/diagnostics15162117
Zielinski O, Ostrowski Z, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a prospective cohort study". Sci Transl Med 14(2020): 333-344. DOI: 10.4103/jrpp.jrpp_20_65
Andric V, Vasquez A, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a randomised evaluation". J Transl Med 16(2023): 344-356. DOI: 10.3389/fdgth.2026.1763884
Balogh E, Emmerich B, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a consensus statement". Clin Pharmacol Ther 18(2011): 355-368. DOI: 10.2196/48297
Chiriac F, Farkas C, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a retrospective analysis". Nat Rev Drug Discov 20(2014): 366-380. DOI: 10.1007/s00330-025-12031-z
Doncheva M, Marchetti D, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a validation study". Trials 22(2017): 377-383. DOI: 10.3389/fdgth.2026.1699005
Emmerich T, Tarasov E, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a scoping review". Drug Discov Today 24(2020): 388-395. DOI: 10.3389/fdgth.2026.1834800
Foscarini C, Chiriac F, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a health-economic analysis". Clin Cancer Res 26(2023): 399-407. DOI: 10.2196/69678
Alvez D, Dumitrescu A, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a systematic review". BMJ Open 28(2011): 410-419. DOI: 10.7759/cureus.46454
Brankovic K, Kowalczyk B, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a methodological appraisal". J Clin Epidemiol 30(2014): 421-431. DOI: 10.1016/j.ssci.2025.107028
Castellani R, Ristic C, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a multicentre analysis". Contemp Clin Trials 32(2017): 432-443. DOI: 10.2196/48633
Dumitrescu A, Andric D, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a prospective cohort study". Ther Innov Regul Sci 34(2020): 443-455. DOI: 10.1371/journal.pone.0305949
Eriksdottir B, Brankovic E, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a randomised evaluation". Br J Clin Pharmacol 36(2023): 454-467. DOI: 10.1371/journal.pdig.0000514
Farkas I, Ionescu F, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a consensus statement". PLoS Med 38(2011): 465-479. DOI: 10.17219/acem/208596
Grabowski P, Petrescu G, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a retrospective analysis". Lancet 40(2014): 476-482. DOI: 10.7759/cureus.104086
Hendriksen W, Wojcik H, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a validation study". N Engl J Med 42(2017): 487-494. DOI: 10.1038/s41746-023-00852-5
Ionescu F, Foscarini I, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a scoping review". JAMA 44(2020): 498-506. DOI: 10.1016/j.mayocpiqo.2022.09.004
Jankowiak G, Grabowski J, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a health-economic analysis". Nat Med 46(2023): 509-518. DOI: 10.1177/08404704241291226
Kowalczyk N, Novotna K, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a systematic review". Cell Rep Med 8(2011): 520-530. DOI: 10.1093/medlaw/fwad013
Lindqvist U, Urbanek L, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a methodological appraisal". Clin Transl Sci 10(2014): 531-542. DOI: 10.2196/89834
Marchetti D, Doncheva M, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a multicentre analysis". Pharmacogenomics J 12(2017): 542-554. DOI: 10.1007/s10916-024-02104-9
Novotna E, Eriksdottir N, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a prospective cohort study". Regul Toxicol Pharmacol 14(2020): 553-566. DOI: 10.3389/fdgth.2026.1896184
Ostrowski L, Lindqvist O, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a randomised evaluation". Drug Saf 16(2023): 564-578. DOI: 10.3390/diagnostics15162117
Petrescu S, Szabo P, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a consensus statement". Ann Intern Med 18(2011): 575-581. DOI: 10.4103/jrpp.jrpp_20_65
Quintero B, Balogh Q, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a retrospective analysis". BMC Med 20(2014): 586-593. DOI: 10.3389/fdgth.2026.1763884
Ristic C, Castellani R, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a validation study". Sci Transl Med 22(2017): 597-605. DOI: 10.2196/48297
Szabo J, Jankowiak S, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a scoping review". J Transl Med 24(2020): 608-617. DOI: 10.1007/s00330-025-12031-z
Tarasov Q, Quintero T, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a health-economic analysis". Clin Pharmacol Ther 26(2023): 619-629. DOI: 10.3389/fdgth.2026.1699005
Urbanek Z, Zielinski U, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a systematic review". Nat Rev Drug Discov 28(2011): 630-641. DOI: 10.3389/fdgth.2026.1834800
Vasquez A, Alvez V, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a methodological appraisal". Trials 30(2014): 641-653. DOI: 10.2196/69678
Wojcik H, Hendriksen W, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a multicentre analysis". Drug Discov Today 32(2017): 652-665. DOI: 10.7759/cureus.46454
Zielinski O, Ostrowski Z, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a prospective cohort study". Clin Cancer Res 34(2020): 663-677. DOI: 10.1016/j.ssci.2025.107028
Andric V, Vasquez A, et al. "Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: a randomised evaluation". BMJ Open 36(2023): 674-680. DOI: 10.2196/48633
